PEP/NEWS — Peptide intel. Daily.

FDA ADVISORY PANEL BACKED BROADER ACCESS TO 4 PEPTIDES INCLUDING BPC-157 AND TB-500LILLY'S RETATRUTIDE (TRIPLE GLP AGONIST) HEADED FOR FDA FILING AFTER PHASE 3 READOUTNICOTINAMIDE RIBOSIDE AND HIGH-INTENSITY EXERCISE PRODUCE NON-OVERLAPPING EPIGENETIC EFFECTS IN MUSCLEVALINE RESTRICTION EXTENDS MOUSE LIFESPAN WITH SEX-SPECIFIC MAGNITUDEENGINEERED CMLASE ENZYME DEGRADES A CLASS OF AGE-RELATED PROTEIN MODIFICATIONS ONCE CONSIDERED PERMANENTAUTOPHAGY DEFICIT IN AGING KIDNEYS LEAVES THEM VULNERABLE TO ACUTE TOXIC INJURY VS YOUNG COUNTERPARTSSTEM CELL EXOSOMES REDUCED METABOLIC LIVER DAMAGE IN MOUSE MODELSNYC LONGEVITY CLINIC DEATH FOLLOWS INTRAVENOUS NAD+ INFUSION — EXPERTS CITE OVERSIGHT FAILURE FDA ADVISORY PANEL BACKED BROADER ACCESS TO 4 PEPTIDES INCLUDING BPC-157 AND TB-500LILLY'S RETATRUTIDE (TRIPLE GLP AGONIST) HEADED FOR FDA FILING AFTER PHASE 3 READOUTNICOTINAMIDE RIBOSIDE AND HIGH-INTENSITY EXERCISE PRODUCE NON-OVERLAPPING EPIGENETIC EFFECTS IN MUSCLEVALINE RESTRICTION EXTENDS MOUSE LIFESPAN WITH SEX-SPECIFIC MAGNITUDEENGINEERED CMLASE ENZYME DEGRADES A CLASS OF AGE-RELATED PROTEIN MODIFICATIONS ONCE CONSIDERED PERMANENTAUTOPHAGY DEFICIT IN AGING KIDNEYS LEAVES THEM VULNERABLE TO ACUTE TOXIC INJURY VS YOUNG COUNTERPARTSSTEM CELL EXOSOMES REDUCED METABOLIC LIVER DAMAGE IN MOUSE MODELSNYC LONGEVITY CLINIC DEATH FOLLOWS INTRAVENOUS NAD+ INFUSION — EXPERTS CITE OVERSIGHT FAILURE

Last updated July 26, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · BioPharma Dive
FDA PANEL ENDORSES BROADER ACCESS FOR BPC-157, KPV, TB-500, AND MOTS-C...

*An FDA advisory panel narrowly backed broader access to four research peptides.*

BioPharma Dive

Featured Briefs

◤ Article · Peptide-anchored

NYC WOMAN DIES FOLLOWING INTRAVENOUS NAD+ INFUSION — EXPERTS WEIGH RISKS...

A New York woman died after receiving an intravenous NAD+ infusion at a longevity clinic. Experts told Lifespan.io the death points to serious risks when unproven IV therapies are delivered without rigorous clinical oversight.

Lifespan.io
▶ Video

SHE LOST HERSELF BEFORE SHE FOUND MRS. AMERICA

🎯 What if the hardest battles of your life happened before anyone ever saw the crown? Before becoming Mrs. Tennessee, Taylor Lavin faced infertility, multiple IVF rounds, three miscarriages, unexplained health struggles, and the feeling th

Dr Debra Durst

More Headlines